13FPulse
中
TL

TLSI TRISALUS LIFE SCIENCES INC

2026Q2 · CUSIP 89680M101 · Sector: Healthcare & Biotech

Funds left

Funds are exiting, but the price is holding

Funds that own it
78
Institutions that reported holding it to the SEC
Net decrease in holders
6
Last quarter 84 → now 78
How unusual is that
Bottom 20%
Stronger than only 19% of US stocks
What the filings say, in one paragraph

78 funds held TLSI at the end of 2026Q2, down 6 from the quarter before. Buying has faded, though the price is holding up. On the business itself, revenue over the last 12 months was $45M(YoY +25.3%), return on equity is -430.7%. TLSI has had 1 buying rushes in its history. It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2023Q4: holders=19 2024Q1: holders=25 2024Q2: holders=27 2024Q3: holders=31 2024Q4: holders=27 2025Q1: holders=34 2025Q2: holders=47 2025Q3: holders=56 2025Q4: holders=64 2026Q1: holders=84 2026Q2: holders=78 -20 -10 +0 +10 +20 175389 23Q424Q124Q224Q324Q425Q125Q225Q325Q426Q126Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 1 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q1 Top 20% — —

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
41
Change in large funds
+2
Total value they hold
$99M
Funds buying for the first time
14
Funds that sold out entirely
20
Price change that quarter
—
Funds holding puts (bearish)
0
Funds holding calls (bullish)
0

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.31
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
+25.3%
Net margin
-62.6%
ROE
-430.7%
Debt ratio
89.5%
FCF (TTM)
-$23M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2024-03-31: EPS -0.60 2024-06-30: EPS -0.21 2024-09-30: EPS -0.12 2024-12-31: EPS -0.38 2025-03-31: EPS -0.39 2025-06-30: EPS -0.27 2025-09-30: EPS -0.96 2025-12-31: EPS -0.22 2026-03-31: EPS 0.03 2026-06-30: EPS -0.16 0M 7M 13M $M -1.06 -0.51 0.03 2022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-40M-20M0K 2023202420252026
Latest quarter $-7M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.